Tramadol Hydrochloride
Product Images NDC 76519-1132

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 76519-1132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H. J. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

76519 1132.jpg (76519 1132)

This image shows a repackaged drug label for TRAMADOL ER 200mg tablets by H. J. Harkins Company Inc. The label includes multiple identical entries for TRAMADOL ER 200mg tablets with NDC 76519-1132-XX, lot number JKS4336A, expiration date 02/28/19, and manufacturer NDC 47335-0860-83 indicating Sun Pharma as the original manufacturer. The label also contains barcodes, a caution statement about prescription use, and instructions to take as directed by a physician.*

FDA Label Image

Fig2.jpg (Fig2)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving response on the y-axis and response threshold (percent improvement from baseline) on the x-axis. The graph compares five dosages of tramadol hydrochloride extended-release tablets (100mg, 200mg, 300mg, 400mg, 500mg) and placebo, illustrating patient response levels across increasing response thresholds.*

FDA Label Image

Tramadol HCl.jpg (Tramadol HCl)

Chemical structure of tramadol hydrochloride, showing its molecular formula representation with functional groups including a methoxy group, hydroxyl group, and hydrochloride component.*

FDA Label Image

Fig3.jpg (Fig3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing the percent of patients achieving response at various levels of response threshold (percent improvement from baseline). Two lines compare Tramadol Hydrochloride Extended-Release Tablets and Placebo across response thresholds from 0 to 100 percent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.